CareLit · DOI-Nachweis · Pneumologie
A Phase 3 Study Design of Pulmaquin® in Non-Cystic Fibrosis Bronchiectasis (NCFBE) Patients Chronically Colonized with Pseudomonas aeruginosa (PA)
DOI 10.1055/s-0036-1592235
Bibliografische Angaben
Nachweis in CareLit
Autor:innenA O'Donnell, D Bilton, D Serisier, A Wanner, J Froehlich, P Bruinenberg, I Gonda
ZeitschriftPneumologie
Ausgabe10/2016
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: Bronchiectasis is a neglected disease in respiratory medicine. In adult NCFBE patients, PA infections are associated with an increased risk of death, hospital admissions and exacerbations. There is no approved treatment to prevent pulmonary exacerbations (PE) in bronchiectasis. Methods: Pulmaquin, a once-a-day inhaled dual-release formulation composed of both liposome encapsulated and unencapsulated ci…
Zitieren
Zitierempfehlung
A O'Donnell, D Bilton, D Serisier, A Wanner, J Froehlich, P Bruinenberg, I Gonda (2016) A Phase 3 Study Design of Pulmaquin® in Non-Cystic Fibrosis Bronchiectasis (NCFBE) Patients Chronically Colonized with Pseudomonas aeruginosa (PA). Pneumologie (10). https://doi.org/10.1055/s-0036-1592235
Mit CareLit weiterarbeiten